These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 16989596)

  • 1. Clinical trials of natural products as chemopreventive agents for prostate cancer.
    Bemis DL; Katz AE; Buttyan R
    Expert Opin Investig Drugs; 2006 Oct; 15(10):1191-200. PubMed ID: 16989596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer chemoprevention by natural agents: Clinical evidence and potential implications.
    Chhabra G; Singh CK; Ndiaye MA; Fedorowicz S; Molot A; Ahmad N
    Cancer Lett; 2018 May; 422():9-18. PubMed ID: 29471004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nutraceuticals and prostate cancer prevention: a current review.
    Trottier G; Boström PJ; Lawrentschuk N; Fleshner NE
    Nat Rev Urol; 2010 Jan; 7(1):21-30. PubMed ID: 19997071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia (HGPIN): a systematic review and adjusted indirect treatment comparison.
    Cui K; Li X; Du Y; Tang X; Arai S; Geng Y; Xi Y; Xu H; Zhou Y; Ma W; Zhang T
    Oncotarget; 2017 May; 8(22):36674-36684. PubMed ID: 28415774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer chemoprevention: current status and future prospects.
    Gupta S
    Toxicol Appl Pharmacol; 2007 Nov; 224(3):369-76. PubMed ID: 17189645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary agents/supplements hit the clinic for prostate cancer chemoprevention.
    Bemis DL; Buttyan R
    Discov Med; 2007 Feb; 7(37):33-8. PubMed ID: 17343803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoprevention of prostate cancer: concepts and strategies.
    Kelloff GJ; Lieberman R; Steele VE; Boone CW; Lubet RA; Kopelovitch L; Malone WA; Crowell JA; Sigman CC
    Eur Urol; 1999; 35(5-6):342-50. PubMed ID: 10325487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary Factors and Supplements Influencing Prostate Specific-Antigen (PSA) Concentrations in Men with Prostate Cancer and Increased Cancer Risk: An Evidence Analysis Review Based on Randomized Controlled Trials.
    Grammatikopoulou MG; Gkiouras K; Papageorgiou SΤ; Myrogiannis I; Mykoniatis I; Papamitsou T; Bogdanos DP; Goulis DG
    Nutrients; 2020 Sep; 12(10):. PubMed ID: 33003518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoprevention of Prostate Cancer by Natural Agents: Evidence from Molecular and Epidemiological Studies.
    Mokbel K; Wazir U; Mokbel K
    Anticancer Res; 2019 Oct; 39(10):5231-5259. PubMed ID: 31570421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary agents for chemoprevention of prostate cancer.
    Syed DN; Suh Y; Afaq F; Mukhtar H
    Cancer Lett; 2008 Jul; 265(2):167-76. PubMed ID: 18395333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of vitamins, minerals and supplements in the prevention and management of prostate cancer.
    Santillo VM; Lowe FC
    Int Braz J Urol; 2006; 32(1):3-14. PubMed ID: 16519822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer prevention: past, present, and future.
    Fleshner N; Zlotta AR
    Cancer; 2007 Nov; 110(9):1889-99. PubMed ID: 17893870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agents, biomarkers, and cohorts for chemopreventive agent development in prostate cancer.
    Kelloff GJ; Lieberman R; Steele VE; Boone CW; Lubet RA; Kopelovich L; Malone WA; Crowell JA; Higley HR; Sigman CC
    Urology; 2001 Apr; 57(4 Suppl 1):46-51. PubMed ID: 11295594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutraceuticals for prostate cancer chemoprevention: from molecular mechanisms to clinical application.
    Wang Z; Fan J; Liu M; Yeung S; Chang A; Chow MS; Pon D; Huang Y
    Expert Opin Investig Drugs; 2013 Dec; 22(12):1613-26. PubMed ID: 24050482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural and synthetic agents targeting inflammation and angiogenesis for chemoprevention of prostate cancer.
    Araldi EM; Dell'aica I; Sogno I; Lorusso G; Garbisa S; Albini A
    Curr Cancer Drug Targets; 2008 Mar; 8(2):146-55. PubMed ID: 18336198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in prostate cancer chemoprevention: a translational perspective.
    Nambiar D; Singh RP
    Nutr Cancer; 2013; 65 Suppl 1():12-25. PubMed ID: 23682779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention of prostate cancer].
    Wirth MP; Hakenberg OW
    Dtsch Med Wochenschr; 2005 Sep; 130(36):2002-4. PubMed ID: 16143928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoprevention of urological cancer.
    Kamat AM; Lamm DL
    J Urol; 1999 Jun; 161(6):1748-60. PubMed ID: 10332429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutrition and prostate cancer: a review.
    Cohen LA
    Ann N Y Acad Sci; 2002 Jun; 963():148-55. PubMed ID: 12095940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug Insight: lycopene in the prevention and treatment of prostate cancer.
    Guns ES; Cowell SP
    Nat Clin Pract Urol; 2005 Jan; 2(1):38-43. PubMed ID: 16474575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.